Otsuka: R&D expenditure 2021

In the fiscal year 2021, Otsuka Holdings Co., Ltd. spent approximately 232.3 billion Japanese yen on research and development, slightly up from around 205.8 billion yen in the previous fiscal year. Otsuka Holdings is a holding company of multiple group companies worldwide such as Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., and Otsuka Chemical.

Research and development (R&D) expenses of Otsuka Holdings Co., Ltd. from fiscal year 2012 to 2021 (in billion Japanese yen)

Characteristic	R&D expenses in billion Japanese yen
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

June 2022

More information

Region

Japan

Survey time period

fiscal year 2012 to 2021; the company's fiscal year starts on January 1st and ends on December 31 of the stated year*

Special properties

excluding impairment losses

Supplementary notes

*Due to a change in the consolidated fiscal year, fiscal 2014 (ended December 31, 2014) was a transitional period covering the nine months from April 1 to December 31, 2014.
Fiscal years until 2013 started on April 1 of the stated year and ended on March 31 of the following year. From fiscal 2015 onwards, fiscal years ended on December 31 of each year.

With effect from fiscal 2016 (ended December 31, 2016), Otsuka adopted the International Financial Reporting Standards (IFRS), on which the presentdisclosure information is based. Information for fiscal 2015 is also presented in line with IFRS.

100 Japanese yen equal 0.74 U.S. dollars or 0.70 euros as of December 2022.
Figures have been rounded.

Citation formats